- Home
- OLP vs PLRX Comparison
OLP vs PLRX Comparison
Compare OLP & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLP
- PLRX
- Stock Information
- Founded
- OLP 1982
- PLRX 2015
- Country
- OLP United States
- PLRX United States
- Employees
- OLP N/A
- PLRX N/A
- Industry
- OLP Real Estate Investment Trusts
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- OLP Real Estate
- PLRX Health Care
- Exchange
- OLP Nasdaq
- PLRX Nasdaq
- Market Cap
- OLP N/A
- PLRX 680.3M
- IPO Year
- OLP N/A
- PLRX 2020
- Fundamental
- Price
- OLP $25.75
- PLRX $11.37
- Analyst Decision
- OLP Strong Buy
- PLRX Strong Buy
- Analyst Count
- OLP 1
- PLRX 7
- Target Price
- OLP $28.00
- PLRX $40.50
- AVG Volume (30 Days)
- OLP 46.6K
- PLRX 485.5K
- Earning Date
- OLP 03-04-2025
- PLRX 02-26-2025
- Dividend Yield
- OLP 7.06%
- PLRX N/A
- EPS Growth
- OLP 51.11
- PLRX N/A
- EPS
- OLP 1.63
- PLRX N/A
- Revenue
- OLP $89,142,000.00
- PLRX N/A
- Revenue This Year
- OLP N/A
- PLRX N/A
- Revenue Next Year
- OLP $4.71
- PLRX N/A
- P/E Ratio
- OLP $15.65
- PLRX N/A
- Revenue Growth
- OLP N/A
- PLRX N/A
- 52 Week Low
- OLP $19.75
- PLRX $10.22
- 52 Week High
- OLP $30.45
- PLRX $18.00
- Technical
- Relative Strength Index (RSI)
- OLP 42.45
- PLRX 44.60
- Support Level
- OLP $25.08
- PLRX $10.35
- Resistance Level
- OLP $25.93
- PLRX $11.07
- Average True Range (ATR)
- OLP 0.53
- PLRX 0.61
- MACD
- OLP 0.09
- PLRX 0.06
- Stochastic Oscillator
- OLP 52.99
- PLRX 43.50
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.